ACUS OTC
Acusphere, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +0.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume125
Avg Volume104
Beta-0.45
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWilliam I. Ramage D.Phil
Employees50
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2003-10-08
Websiteacusphere.com
500 Arsenal Street
Watertown, MA 02472
US
Watertown, MA 02472
US
617-648-8800
About Acusphere, Inc.
Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Gyenes Lawrence A | P-Purchase | 51,239 | $0.56 | 2008-07-25 |
| Gyenes Lawrence A | A-Award | 200,000 | $0.57 | 2008-02-01 |
| Gyenes Lawrence A | A-Award | 200,000 | $1.15 | 2007-11-15 |
| Gyenes Lawrence A | 0 | — | 2007-10-01 | |
| THERO JOHN F | M-Exempt | 70,000 | $0.84 | 2007-08-28 |